Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 48 | 2024 | 6962 | 3.210 |
Why?
|
Aspirin | 14 | 2024 | 3134 | 1.880 |
Why?
|
Escherichia coli Proteins | 7 | 2024 | 1055 | 1.700 |
Why?
|
Aberrant Crypt Foci | 3 | 2017 | 12 | 1.490 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 8 | 2024 | 2270 | 1.350 |
Why?
|
Membrane Proteins | 10 | 2018 | 7866 | 1.240 |
Why?
|
Saccharomyces cerevisiae | 8 | 2018 | 2678 | 1.100 |
Why?
|
Anticarcinogenic Agents | 3 | 2018 | 251 | 1.090 |
Why?
|
Fibroblast Growth Factors | 3 | 2020 | 871 | 1.040 |
Why?
|
Escherichia coli | 5 | 2024 | 4211 | 0.950 |
Why?
|
Renal Dialysis | 3 | 2024 | 1790 | 0.900 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2017 | 594 | 0.850 |
Why?
|
Adenoma | 6 | 2021 | 2155 | 0.840 |
Why?
|
Feces | 7 | 2024 | 1505 | 0.810 |
Why?
|
Body Composition | 3 | 2020 | 2441 | 0.800 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2023 | 393 | 0.760 |
Why?
|
Chemoprevention | 3 | 2020 | 327 | 0.750 |
Why?
|
Prokaryotic Cells | 2 | 2018 | 53 | 0.720 |
Why?
|
Crystallography, X-Ray | 4 | 2013 | 1947 | 0.690 |
Why?
|
Cryoelectron Microscopy | 1 | 2024 | 645 | 0.680 |
Why?
|
Potassium | 1 | 2024 | 1314 | 0.670 |
Why?
|
Liposomes | 1 | 2023 | 787 | 0.650 |
Why?
|
Green Fluorescent Proteins | 5 | 2012 | 2062 | 0.640 |
Why?
|
Glucose Transport Proteins, Facilitative | 1 | 2018 | 58 | 0.580 |
Why?
|
Health | 1 | 2020 | 397 | 0.580 |
Why?
|
Stomach Neoplasms | 3 | 2024 | 1474 | 0.570 |
Why?
|
Dinoprostone | 1 | 2020 | 597 | 0.570 |
Why?
|
Eukaryotic Cells | 1 | 2018 | 191 | 0.570 |
Why?
|
Carcinoma | 3 | 2017 | 2323 | 0.560 |
Why?
|
Colonoscopy | 4 | 2024 | 1409 | 0.530 |
Why?
|
Detergents | 3 | 2013 | 235 | 0.530 |
Why?
|
Crystallization | 3 | 2014 | 518 | 0.490 |
Why?
|
Thermus thermophilus | 2 | 2017 | 20 | 0.480 |
Why?
|
Industrial Microbiology | 1 | 2014 | 7 | 0.480 |
Why?
|
Smoking | 6 | 2024 | 9076 | 0.470 |
Why?
|
Colonic Polyps | 2 | 2019 | 557 | 0.470 |
Why?
|
Data Collection | 2 | 2020 | 3321 | 0.450 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2023 | 2306 | 0.440 |
Why?
|
Genome-Wide Association Study | 8 | 2024 | 12803 | 0.440 |
Why?
|
International Cooperation | 1 | 2020 | 1434 | 0.430 |
Why?
|
Aging | 4 | 2020 | 8724 | 0.430 |
Why?
|
Microsatellite Instability | 6 | 2024 | 726 | 0.420 |
Why?
|
Hypertension | 3 | 2023 | 8614 | 0.410 |
Why?
|
Protein Stability | 5 | 2018 | 577 | 0.410 |
Why?
|
Polymorphism, Single Nucleotide | 11 | 2024 | 16040 | 0.410 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3109 | 0.400 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3231 | 0.400 |
Why?
|
Molecular Dynamics Simulation | 4 | 2024 | 422 | 0.390 |
Why?
|
Chromatography, Gel | 4 | 2018 | 634 | 0.390 |
Why?
|
Colonic Neoplasms | 4 | 2020 | 2533 | 0.390 |
Why?
|
Gene Expression | 4 | 2020 | 7583 | 0.390 |
Why?
|
Organic Anion Transporters, Sodium-Dependent | 1 | 2011 | 26 | 0.390 |
Why?
|
Postprandial Period | 4 | 2021 | 320 | 0.390 |
Why?
|
Symporters | 2 | 2011 | 362 | 0.380 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1943 | 0.380 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2014 | 404 | 0.380 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 474 | 0.380 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 478 | 0.370 |
Why?
|
Neisseria meningitidis | 1 | 2011 | 111 | 0.370 |
Why?
|
Dietary Fiber | 4 | 2024 | 767 | 0.370 |
Why?
|
Metagenome | 5 | 2023 | 464 | 0.360 |
Why?
|
Patient Discharge | 1 | 2024 | 3464 | 0.360 |
Why?
|
Proteomics | 4 | 2024 | 3906 | 0.360 |
Why?
|
Risk Factors | 37 | 2024 | 74825 | 0.350 |
Why?
|
Aged | 50 | 2024 | 171208 | 0.350 |
Why?
|
Recombinant Fusion Proteins | 4 | 2012 | 3735 | 0.350 |
Why?
|
Diet | 12 | 2024 | 8085 | 0.340 |
Why?
|
Humans | 112 | 2024 | 766351 | 0.340 |
Why?
|
Hyperplasia | 1 | 2013 | 1150 | 0.330 |
Why?
|
Immunoassay | 1 | 2013 | 742 | 0.330 |
Why?
|
Prospective Studies | 32 | 2024 | 54809 | 0.330 |
Why?
|
Plasmids | 2 | 2012 | 2267 | 0.320 |
Why?
|
Genetic Predisposition to Disease | 9 | 2024 | 18075 | 0.320 |
Why?
|
Deoxycholic Acid | 1 | 2008 | 54 | 0.310 |
Why?
|
Protein Conformation | 3 | 2014 | 3946 | 0.310 |
Why?
|
DNA, Neoplasm | 1 | 2014 | 1741 | 0.310 |
Why?
|
Kidney Failure, Chronic | 2 | 2024 | 2505 | 0.310 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2008 | 105 | 0.300 |
Why?
|
Proto-Oncogene Proteins B-raf | 6 | 2024 | 2055 | 0.300 |
Why?
|
Incidence | 10 | 2024 | 21506 | 0.300 |
Why?
|
Fusobacterium nucleatum | 2 | 2021 | 176 | 0.300 |
Why?
|
Cell Membrane | 1 | 2017 | 3640 | 0.290 |
Why?
|
Sodium | 3 | 2022 | 1593 | 0.290 |
Why?
|
Middle Aged | 52 | 2024 | 223092 | 0.290 |
Why?
|
Glucose Transporter Type 1 | 2 | 2023 | 186 | 0.290 |
Why?
|
Male | 64 | 2024 | 363931 | 0.290 |
Why?
|
Colon | 3 | 2021 | 1798 | 0.290 |
Why?
|
Models, Molecular | 3 | 2013 | 5385 | 0.290 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2019 | 1105 | 0.280 |
Why?
|
Female | 65 | 2024 | 396307 | 0.280 |
Why?
|
Irritable Bowel Syndrome | 2 | 2023 | 454 | 0.280 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2023 | 388 | 0.280 |
Why?
|
Self Report | 8 | 2022 | 3769 | 0.280 |
Why?
|
Folic Acid | 2 | 2024 | 1337 | 0.270 |
Why?
|
Biotechnology | 1 | 2008 | 283 | 0.250 |
Why?
|
Vaccination | 4 | 2022 | 3434 | 0.250 |
Why?
|
Blood Pressure | 2 | 2023 | 8532 | 0.250 |
Why?
|
Case-Control Studies | 10 | 2024 | 22243 | 0.240 |
Why?
|
Membrane Transport Proteins | 3 | 2024 | 1029 | 0.240 |
Why?
|
Potassium-Hydrogen Antiporters | 1 | 2024 | 2 | 0.240 |
Why?
|
CpG Islands | 5 | 2024 | 1208 | 0.240 |
Why?
|
Protons | 3 | 2022 | 1097 | 0.230 |
Why?
|
Genetic Vectors | 2 | 2012 | 3400 | 0.230 |
Why?
|
Recombinant Proteins | 2 | 2012 | 6507 | 0.230 |
Why?
|
Receptors, Prostaglandin E, EP4 Subtype | 1 | 2024 | 44 | 0.230 |
Why?
|
Probenecid | 1 | 2024 | 72 | 0.230 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2012 | 1245 | 0.230 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2022 | 2477 | 0.220 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2024 | 4652 | 0.220 |
Why?
|
Glucose Transporter Type 3 | 1 | 2023 | 16 | 0.220 |
Why?
|
Antiporters | 2 | 2022 | 275 | 0.220 |
Why?
|
Mutation | 10 | 2024 | 30217 | 0.220 |
Why?
|
Cognition | 6 | 2024 | 7057 | 0.220 |
Why?
|
Blood Glucose | 4 | 2021 | 6422 | 0.210 |
Why?
|
Microdissection | 2 | 2014 | 150 | 0.210 |
Why?
|
Feeding Behavior | 4 | 2021 | 3208 | 0.210 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2023 | 174 | 0.200 |
Why?
|
Histidine | 1 | 2022 | 301 | 0.190 |
Why?
|
Ions | 1 | 2022 | 254 | 0.190 |
Why?
|
Salicylic Acid | 1 | 2021 | 62 | 0.190 |
Why?
|
Ageusia | 1 | 2021 | 18 | 0.190 |
Why?
|
Glutathione | 1 | 2024 | 589 | 0.190 |
Why?
|
Mendelian Randomization Analysis | 3 | 2024 | 1038 | 0.190 |
Why?
|
Adult | 40 | 2024 | 223220 | 0.190 |
Why?
|
DNA Glycosylases | 1 | 2022 | 125 | 0.190 |
Why?
|
Pandemics | 8 | 2022 | 8728 | 0.180 |
Why?
|
Mass Spectrometry | 3 | 2024 | 2196 | 0.180 |
Why?
|
Proportional Hazards Models | 7 | 2022 | 12527 | 0.180 |
Why?
|
Biological Assay | 1 | 2024 | 626 | 0.180 |
Why?
|
Follow-Up Studies | 14 | 2023 | 39269 | 0.180 |
Why?
|
Kidney Tubules | 1 | 2022 | 453 | 0.180 |
Why?
|
Community Health Centers | 1 | 2024 | 469 | 0.180 |
Why?
|
Progestins | 1 | 2022 | 300 | 0.170 |
Why?
|
Genetic Loci | 3 | 2024 | 2630 | 0.170 |
Why?
|
Cough | 2 | 2021 | 599 | 0.170 |
Why?
|
Disease Progression | 6 | 2023 | 13623 | 0.170 |
Why?
|
Neuropsychological Tests | 3 | 2024 | 7119 | 0.170 |
Why?
|
Early Detection of Cancer | 2 | 2024 | 3236 | 0.170 |
Why?
|
Disease Notification | 1 | 2020 | 95 | 0.170 |
Why?
|
Precancerous Conditions | 2 | 2019 | 980 | 0.160 |
Why?
|
Genes, Reporter | 2 | 2018 | 1525 | 0.160 |
Why?
|
Bacterial Proteins | 2 | 2017 | 3833 | 0.160 |
Why?
|
DNA Methylation | 6 | 2024 | 4427 | 0.160 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5883 | 0.160 |
Why?
|
Appetite | 1 | 2021 | 247 | 0.160 |
Why?
|
Risk Assessment | 8 | 2024 | 24272 | 0.160 |
Why?
|
Dyspnea | 3 | 2021 | 1350 | 0.160 |
Why?
|
Masks | 1 | 2021 | 212 | 0.150 |
Why?
|
Fruit | 1 | 2024 | 1166 | 0.150 |
Why?
|
Time Factors | 9 | 2021 | 40112 | 0.150 |
Why?
|
Vegetables | 1 | 2024 | 1199 | 0.150 |
Why?
|
Glucosinolates | 1 | 2018 | 11 | 0.150 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2660 | 0.150 |
Why?
|
Systole | 2 | 2020 | 934 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 812 | 0.150 |
Why?
|
Isothiocyanates | 1 | 2018 | 48 | 0.150 |
Why?
|
Kidney Transplantation | 2 | 2024 | 4278 | 0.150 |
Why?
|
Diastole | 2 | 2020 | 783 | 0.150 |
Why?
|
Mammals | 1 | 2023 | 1134 | 0.140 |
Why?
|
Gastroenterology | 1 | 2024 | 593 | 0.140 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 249 | 0.140 |
Why?
|
United States | 15 | 2022 | 72909 | 0.140 |
Why?
|
Young Adult | 15 | 2022 | 59906 | 0.140 |
Why?
|
Prognosis | 8 | 2021 | 29921 | 0.140 |
Why?
|
Biological Availability | 1 | 2018 | 387 | 0.140 |
Why?
|
Epidemiologic Studies | 2 | 2021 | 677 | 0.140 |
Why?
|
Aged, 80 and over | 13 | 2022 | 59527 | 0.140 |
Why?
|
Fever | 2 | 2021 | 1607 | 0.140 |
Why?
|
Double-Blind Method | 3 | 2023 | 12423 | 0.140 |
Why?
|
Apathy | 1 | 2017 | 107 | 0.140 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14756 | 0.130 |
Why?
|
Calcitriol | 1 | 2018 | 301 | 0.130 |
Why?
|
REM Sleep Behavior Disorder | 1 | 2017 | 111 | 0.130 |
Why?
|
Lipid Bilayers | 1 | 2018 | 376 | 0.130 |
Why?
|
Nursing Research | 1 | 2017 | 79 | 0.130 |
Why?
|
Cohort Studies | 10 | 2024 | 41698 | 0.130 |
Why?
|
Professional-Family Relations | 1 | 2000 | 500 | 0.130 |
Why?
|
Germ-Line Mutation | 2 | 2022 | 1885 | 0.130 |
Why?
|
Water | 1 | 2022 | 1417 | 0.130 |
Why?
|
Biomimetics | 1 | 2017 | 168 | 0.130 |
Why?
|
Cytokines | 2 | 2024 | 7436 | 0.130 |
Why?
|
Obesity | 4 | 2023 | 13087 | 0.130 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2021 | 698 | 0.130 |
Why?
|
Prostaglandins | 1 | 2017 | 398 | 0.130 |
Why?
|
Kinetics | 1 | 2023 | 6285 | 0.130 |
Why?
|
Protein Structure, Tertiary | 2 | 2013 | 3757 | 0.120 |
Why?
|
Metagenomics | 4 | 2021 | 473 | 0.120 |
Why?
|
Protein Unfolding | 2 | 2017 | 57 | 0.120 |
Why?
|
Prevalence | 3 | 2021 | 15820 | 0.120 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 26279 | 0.120 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1362 | 0.120 |
Why?
|
Mass Screening | 3 | 2020 | 5451 | 0.120 |
Why?
|
Organoids | 1 | 2021 | 741 | 0.120 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15897 | 0.120 |
Why?
|
Structure-Activity Relationship | 2 | 2018 | 3053 | 0.120 |
Why?
|
Sleep Deprivation | 1 | 2021 | 848 | 0.120 |
Why?
|
Protein Binding | 3 | 2018 | 9315 | 0.120 |
Why?
|
Binding Sites | 4 | 2024 | 6010 | 0.120 |
Why?
|
Chemical Fractionation | 1 | 2014 | 60 | 0.120 |
Why?
|
Bacteria | 3 | 2021 | 2212 | 0.120 |
Why?
|
Tumor Escape | 1 | 2017 | 372 | 0.120 |
Why?
|
Health Personnel | 4 | 2021 | 3382 | 0.110 |
Why?
|
Glucose | 2 | 2023 | 4339 | 0.110 |
Why?
|
Cell Fractionation | 1 | 2014 | 245 | 0.110 |
Why?
|
Sex Factors | 4 | 2021 | 10614 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 4 | 2024 | 1765 | 0.110 |
Why?
|
Energy Intake | 1 | 2021 | 2142 | 0.110 |
Why?
|
Ambulatory Care | 1 | 2024 | 2778 | 0.100 |
Why?
|
Static Electricity | 1 | 2013 | 258 | 0.100 |
Why?
|
Life Style | 1 | 2024 | 3926 | 0.100 |
Why?
|
Dyslipidemias | 1 | 2020 | 871 | 0.100 |
Why?
|
Models, Chemical | 1 | 2014 | 607 | 0.100 |
Why?
|
Vitamin D Deficiency | 1 | 2022 | 1347 | 0.100 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2024 | 2184 | 0.100 |
Why?
|
Adolescent | 11 | 2021 | 88877 | 0.100 |
Why?
|
Triglycerides | 1 | 2020 | 2441 | 0.100 |
Why?
|
Intestinal Mucosa | 2 | 2014 | 3048 | 0.100 |
Why?
|
Educational Status | 1 | 2020 | 2509 | 0.100 |
Why?
|
Cloning, Molecular | 1 | 2018 | 4167 | 0.100 |
Why?
|
Inflammation Mediators | 2 | 2021 | 1889 | 0.100 |
Why?
|
Galactokinase | 1 | 2012 | 18 | 0.100 |
Why?
|
Eukaryota | 1 | 2013 | 101 | 0.100 |
Why?
|
ROC Curve | 1 | 2020 | 3616 | 0.100 |
Why?
|
Peptides | 1 | 2024 | 4344 | 0.100 |
Why?
|
Metabolomics | 1 | 2021 | 1675 | 0.100 |
Why?
|
Stilbenes | 1 | 2012 | 154 | 0.100 |
Why?
|
Adenocarcinoma | 2 | 2022 | 6361 | 0.100 |
Why?
|
Promoter Regions, Genetic | 2 | 2014 | 5789 | 0.100 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 15390 | 0.090 |
Why?
|
Age Factors | 4 | 2021 | 18395 | 0.090 |
Why?
|
Tumor Microenvironment | 3 | 2020 | 3943 | 0.090 |
Why?
|
Shewanella | 1 | 2010 | 12 | 0.090 |
Why?
|
Aspartic Acid | 1 | 2013 | 575 | 0.090 |
Why?
|
Clinical Protocols | 1 | 2017 | 1437 | 0.090 |
Why?
|
Protein Disulfide-Isomerases | 1 | 2012 | 209 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2594 | 0.090 |
Why?
|
Alleles | 1 | 2022 | 6894 | 0.090 |
Why?
|
Models, Biological | 3 | 2021 | 9458 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2020 | 2029 | 0.090 |
Why?
|
Risk Reduction Behavior | 1 | 2017 | 1120 | 0.090 |
Why?
|
Genes, ras | 1 | 2013 | 657 | 0.090 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2012 | 1836 | 0.090 |
Why?
|
Vesicular Glutamate Transport Protein 2 | 1 | 2010 | 63 | 0.090 |
Why?
|
Cause of Death | 1 | 2020 | 3714 | 0.080 |
Why?
|
Body Weight | 1 | 2020 | 4625 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12060 | 0.080 |
Why?
|
Phenotype | 4 | 2024 | 16718 | 0.080 |
Why?
|
Bile Acids and Salts | 1 | 2011 | 398 | 0.080 |
Why?
|
Exercise | 2 | 2023 | 5943 | 0.080 |
Why?
|
Biological Transport | 2 | 2024 | 2083 | 0.080 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6217 | 0.080 |
Why?
|
Protein Folding | 1 | 2013 | 868 | 0.080 |
Why?
|
Health Status | 2 | 2020 | 4085 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2529 | 0.080 |
Why?
|
Terminal Care | 1 | 2000 | 1769 | 0.080 |
Why?
|
Dementia | 1 | 2023 | 2741 | 0.080 |
Why?
|
Protein Multimerization | 1 | 2013 | 960 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3601 | 0.070 |
Why?
|
Constipation | 2 | 2023 | 568 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2020 | 3562 | 0.070 |
Why?
|
Phosphorylation | 2 | 2024 | 8300 | 0.070 |
Why?
|
Ultraviolet Rays | 1 | 2013 | 1101 | 0.070 |
Why?
|
Glomerular Filtration Rate | 3 | 2023 | 2230 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4356 | 0.070 |
Why?
|
Nanotechnology | 1 | 2013 | 702 | 0.070 |
Why?
|
Animals | 8 | 2024 | 168887 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8536 | 0.070 |
Why?
|
Genome, Human | 1 | 2020 | 4443 | 0.070 |
Why?
|
Risk | 2 | 2016 | 9601 | 0.070 |
Why?
|
Mutant Proteins | 1 | 2008 | 487 | 0.070 |
Why?
|
Sleep | 1 | 2022 | 4815 | 0.070 |
Why?
|
Diet Surveys | 2 | 2021 | 1159 | 0.070 |
Why?
|
Decision Making | 1 | 2000 | 3955 | 0.070 |
Why?
|
Parents | 1 | 2000 | 3595 | 0.070 |
Why?
|
Anxiety | 1 | 2021 | 4669 | 0.070 |
Why?
|
Genomics | 1 | 2022 | 5924 | 0.070 |
Why?
|
Diarrhea | 2 | 2023 | 1317 | 0.060 |
Why?
|
Software | 1 | 2020 | 4464 | 0.060 |
Why?
|
Lipids | 1 | 2017 | 3319 | 0.060 |
Why?
|
Insulin | 1 | 2020 | 6608 | 0.060 |
Why?
|
Comorbidity | 1 | 2020 | 10579 | 0.060 |
Why?
|
Independent Living | 2 | 2020 | 584 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1963 | 0.060 |
Why?
|
Menopause | 2 | 2024 | 1657 | 0.060 |
Why?
|
Temperature | 1 | 2012 | 2229 | 0.060 |
Why?
|
Molecular Epidemiology | 2 | 2017 | 472 | 0.060 |
Why?
|
Smoking Cessation | 1 | 2017 | 2082 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9521 | 0.060 |
Why?
|
Inflammation | 2 | 2023 | 10860 | 0.060 |
Why?
|
Body Mass Index | 4 | 2024 | 13043 | 0.060 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2007 | 496 | 0.060 |
Why?
|
Epidemiologic Factors | 1 | 2024 | 36 | 0.060 |
Why?
|
Depression | 2 | 2021 | 8228 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9333 | 0.060 |
Why?
|
Genotype | 3 | 2024 | 13032 | 0.050 |
Why?
|
Histones | 1 | 2014 | 2591 | 0.050 |
Why?
|
Occult Blood | 1 | 2024 | 199 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2021 | 3664 | 0.050 |
Why?
|
Archaea | 1 | 2023 | 59 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2017 | 2432 | 0.050 |
Why?
|
Electron Transport Complex IV | 1 | 2022 | 188 | 0.050 |
Why?
|
Trophoblasts | 1 | 2023 | 223 | 0.050 |
Why?
|
Neoplasms | 2 | 2020 | 22343 | 0.050 |
Why?
|
Microscopy, Confocal | 1 | 2007 | 1967 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5860 | 0.050 |
Why?
|
Reminder Systems | 1 | 2024 | 388 | 0.050 |
Why?
|
Rats | 2 | 2024 | 23718 | 0.050 |
Why?
|
Body Size | 1 | 2024 | 460 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2023 | 638 | 0.050 |
Why?
|
Research Design | 1 | 2017 | 6205 | 0.050 |
Why?
|
Satiation | 1 | 2021 | 84 | 0.050 |
Why?
|
Prevotella | 1 | 2021 | 81 | 0.050 |
Why?
|
Meat | 1 | 2024 | 588 | 0.050 |
Why?
|
Food Microbiology | 1 | 2021 | 73 | 0.040 |
Why?
|
Dietary Supplements | 2 | 2024 | 3427 | 0.040 |
Why?
|
Blastocystis | 1 | 2021 | 21 | 0.040 |
Why?
|
Southeastern United States | 1 | 2000 | 94 | 0.040 |
Why?
|
Alcohol Drinking | 2 | 2024 | 4044 | 0.040 |
Why?
|
Hong Kong | 1 | 2000 | 169 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11059 | 0.040 |
Why?
|
Taste Disorders | 1 | 2020 | 37 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2014 | 8619 | 0.040 |
Why?
|
Confidentiality | 1 | 2024 | 607 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2020 | 50 | 0.040 |
Why?
|
Eicosapentaenoic Acid | 1 | 2023 | 565 | 0.040 |
Why?
|
Logistic Models | 2 | 2024 | 13274 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 167 | 0.040 |
Why?
|
Sulfur | 1 | 2020 | 158 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2023 | 877 | 0.040 |
Why?
|
England | 1 | 2020 | 533 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2020 | 266 | 0.040 |
Why?
|
Hunger | 1 | 2021 | 207 | 0.040 |
Why?
|
Glycemic Index | 1 | 2021 | 400 | 0.040 |
Why?
|
Neoplasm Seeding | 1 | 2019 | 85 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1731 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2020 | 8716 | 0.040 |
Why?
|
Israel | 1 | 2021 | 722 | 0.040 |
Why?
|
Life Support Care | 1 | 2000 | 226 | 0.040 |
Why?
|
Sigmoidoscopy | 1 | 2019 | 150 | 0.040 |
Why?
|
Computer Systems | 1 | 2020 | 467 | 0.040 |
Why?
|
Individuality | 1 | 2020 | 303 | 0.040 |
Why?
|
Hormone Replacement Therapy | 1 | 2024 | 751 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7475 | 0.040 |
Why?
|
C-Peptide | 1 | 2020 | 443 | 0.040 |
Why?
|
Resuscitation Orders | 1 | 2000 | 271 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2021 | 2839 | 0.040 |
Why?
|
Microfilament Proteins | 1 | 2023 | 1129 | 0.040 |
Why?
|
Informed Consent | 1 | 2024 | 1010 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2024 | 1851 | 0.040 |
Why?
|
Olfaction Disorders | 1 | 2020 | 225 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13639 | 0.040 |
Why?
|
Estrogen Replacement Therapy | 1 | 2024 | 1205 | 0.040 |
Why?
|
Mental Health | 2 | 2022 | 3270 | 0.040 |
Why?
|
Public Health | 2 | 2021 | 2681 | 0.040 |
Why?
|
Cross-Cultural Comparison | 1 | 2000 | 636 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2020 | 1180 | 0.030 |
Why?
|
Odds Ratio | 2 | 2021 | 9653 | 0.030 |
Why?
|
Levodopa | 1 | 2017 | 221 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10379 | 0.030 |
Why?
|
Australia | 1 | 2000 | 1262 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2023 | 2002 | 0.030 |
Why?
|
Safety | 1 | 2021 | 1157 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1186 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2023 | 1657 | 0.030 |
Why?
|
Vaccines, DNA | 1 | 1997 | 279 | 0.030 |
Why?
|
Eating | 1 | 2022 | 1538 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 12236 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 1044 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2021 | 2919 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2022 | 857 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2021 | 560 | 0.030 |
Why?
|
Estrogens | 1 | 2022 | 1528 | 0.030 |
Why?
|
Heterozygote | 1 | 2022 | 2795 | 0.030 |
Why?
|
Dietary Carbohydrates | 1 | 2020 | 896 | 0.030 |
Why?
|
Executive Function | 1 | 2024 | 1396 | 0.030 |
Why?
|
Dopamine Agonists | 1 | 2017 | 346 | 0.030 |
Why?
|
Crack Cocaine | 1 | 1995 | 33 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2023 | 65201 | 0.030 |
Why?
|
Dietary Proteins | 1 | 2020 | 960 | 0.030 |
Why?
|
Postmenopause | 1 | 2024 | 2517 | 0.030 |
Why?
|
Colectomy | 1 | 2020 | 696 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1071 | 0.030 |
Why?
|
Minority Groups | 1 | 2022 | 1208 | 0.030 |
Why?
|
Fasting | 1 | 2021 | 1609 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1790 | 0.030 |
Why?
|
Chest Pain | 1 | 2021 | 1100 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2016 | 794 | 0.030 |
Why?
|
DNA Damage | 1 | 2024 | 2464 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14643 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1725 | 0.030 |
Why?
|
Heart Failure | 1 | 2018 | 11815 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2022 | 4113 | 0.030 |
Why?
|
Random Allocation | 1 | 2018 | 2393 | 0.030 |
Why?
|
Vitamins | 1 | 2022 | 1630 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2020 | 1319 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2038 | 0.030 |
Why?
|
Dimerization | 1 | 2014 | 882 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2020 | 1755 | 0.030 |
Why?
|
Fatigue | 1 | 2020 | 1554 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 283 | 0.030 |
Why?
|
Dietary Fats | 1 | 2020 | 2001 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2020 | 2352 | 0.020 |
Why?
|
Pregnancy | 2 | 2024 | 30229 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4410 | 0.020 |
Why?
|
Multifactorial Inheritance | 1 | 2020 | 1424 | 0.020 |
Why?
|
Antigens, Bacterial | 1 | 1997 | 1148 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 856 | 0.020 |
Why?
|
Crystallography | 1 | 2010 | 110 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 505 | 0.020 |
Why?
|
Polysomnography | 1 | 2017 | 1868 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2012 | 873 | 0.020 |
Why?
|
Phylogeny | 1 | 2018 | 2839 | 0.020 |
Why?
|
Viral Proteins | 1 | 2017 | 1801 | 0.020 |
Why?
|
Cocaine | 1 | 1995 | 944 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2020 | 2947 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3852 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2000 | 5302 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1752 | 0.020 |
Why?
|
Bacterial Infections | 1 | 1997 | 1390 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3403 | 0.020 |
Why?
|
Vitamin D | 1 | 2022 | 3269 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1896 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7840 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2021 | 81577 | 0.020 |
Why?
|
Nurses | 1 | 2017 | 2503 | 0.020 |
Why?
|
Mortality | 1 | 2018 | 2907 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8885 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9352 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1351 | 0.020 |
Why?
|
Emotions | 1 | 2017 | 2758 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2023 | 11648 | 0.020 |
Why?
|
Mice | 2 | 2024 | 81863 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6778 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9401 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5021 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2012 | 6105 | 0.020 |
Why?
|
Genetic Variation | 1 | 2020 | 6611 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18322 | 0.010 |
Why?
|
Parkinson Disease | 1 | 2017 | 2884 | 0.010 |
Why?
|
Kidney | 1 | 2018 | 7071 | 0.010 |
Why?
|
Child | 2 | 2021 | 80653 | 0.010 |
Why?
|
Chromatin | 1 | 2014 | 2979 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5890 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13472 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1918 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7426 | 0.010 |
Why?
|
Heart Diseases | 1 | 1995 | 2814 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 8060 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6256 | 0.010 |
Why?
|
Signal Transduction | 1 | 2024 | 23611 | 0.010 |
Why?
|
Thrombosis | 1 | 1995 | 2950 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2014 | 7607 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10438 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 1995 | 4418 | 0.010 |
Why?
|
Chlamydia trachomatis | 1 | 1997 | 239 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15638 | 0.010 |
Why?
|
Echocardiography | 2 | 1995 | 5030 | 0.010 |
Why?
|
Chlamydia Infections | 1 | 1997 | 365 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 1995 | 11501 | 0.010 |
Why?
|
Heart Ventricles | 2 | 1995 | 3821 | 0.000 |
Why?
|
Mycobacterium tuberculosis | 1 | 1997 | 1910 | 0.000 |
Why?
|
Tuberculosis | 1 | 1997 | 2010 | 0.000 |
Why?
|
Electrocardiography | 1 | 1995 | 6378 | 0.000 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1979 | 452 | 0.000 |
Why?
|
Heart Valve Diseases | 1 | 1979 | 1029 | 0.000 |
Why?
|
Radiography | 1 | 1979 | 6967 | 0.000 |
Why?
|
Coronary Disease | 1 | 1979 | 5914 | 0.000 |
Why?
|